¼¼°èÀÇ Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå, ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼ : ¹æ»ç¼± À¯Çüº°, Ä¡·áº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, ¿¹Ãø(2025-2034³â)
Radiation Therapy in the Oncology Market Size, Share, Trends, & Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), By Therapy, By End-User, and By Region - Market Forecast, 2025-2034
Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é Á¾¾çÇÐ ºÐ¾ß ¹æ»ç¼± Ä¡·á ¼¼°è ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 154¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
Á¾¾çÇÐ ºÐ¾ßÀÇ ¹æ»ç¼± Ä¡·á ½ÃÀåÀº ¾Ï Ä¡·á ¹× °ü¸®¸¦ À§ÇÑ °í¿¡³ÊÁö ÀÌ¿ÂÈ ¹æ»ç¼±ÀÇ È°¿ëÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ Ä¡·á¹ý¿¡¼´Â ÁÖº¯ °Ç°ÇÑ Á¶Á÷°ú Àå±âÀÇ ¼Õ»óÀ» ÃÖ¼ÒÈÇÏ¸é¼ ¾Ï¼¼Æ÷ÀÇ ¹Ú¸ê°ú Áõ½Ä ¾ïÁ¦¸¦ ¸ñÀûÀ¸·Î ¾Ç¼º Á¾¾ç¿¡ Á¤È®ÇÏ°Ô ¹æ»ç¼±À» Á¶»çÇß½À´Ï´Ù. ¸®´Ï¾î¸¯À» ÀÌ¿ëÇÑ ¿ÜºÎÁ¶»çÄ¡·á(EBRT), ü³»¿¡ ¹æ»ç¼º ¼±¿øÀ» ¼³Ä¡Çϴ ü³»Á¶»çÄ¡·á(Brachytherapy), Àü½ÅÀ» ¼øÈ¯ÇÏ´Â ¹æ»ç¼º ¹°ÁúÀ» ÀÌ¿ëÇÑ Àü½ÅÁ¶»çÄ¡·á µî ´Ù¾çÇÑ ¹æ»ç¼±¿ø°ú Á¶»ç±â¼úÀÌ ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¹æ»ç¼±Á¾¾çÇÐ ºÐ¾ß´Â ÷´Ü ¿µ»óÁø´Ü, Ä¡·á°èȹ ¼ÒÇÁÆ®¿þ¾î, Àü¹® ÀÇ·áÁö½ÄÀ» ÅëÇÕÇÏ¿© ´Ù¾çÇÑ Á¾¾ç À¯Çü°ú º´±â¿¡ °ÉÄ£ ¾ÏȯÀÚÀÇ Ä¡·á °á°ú¸¦ ÃÖÀûÈÇÕ´Ï´Ù.
ÀÌ ½ÃÀåÀº Àü ¼¼°è ¾Ï ¹ßº´·ü Áõ°¡¿Í ¹æ»ç¼± Á¶»ç ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü¿¡ ÈûÀÔ¾î ±¤¹üÀ§ÇÑ ¹æ»ç¼± Á¾¾çÇÐ Àü¸Á¿¡¼ Áß¿äÇÑ ºÎ¹®ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå °³¿ä´Â ¹æ»ç¼± Ä¡·á¸¦ °³º° ȯÀÚ ¹× Á¾¾ç Ư¼º¿¡ ¸Â°Ô Á¶Á¤ÇÏ´Â ¸ÂÃã ÀÇ·áÀÇ È®»ê°ú °°Àº ¿äÀο¡ ÀÇÇØ ¿µÇâÀ» ¹Þ´Â ¿ªµ¿ÀûÀΠȯ°æÀ» º¸¿©ÁÝ´Ï´Ù. °µµº¯Á¶¹æ»ç¼±Ä¡·á(IMRT), ¿µ»óÀ¯µµ¹æ»ç¼±Ä¡·á(IGRT), ¾ç¼ºÀÚÄ¡·á, ÀÚ±â°ø¸íÀ¯µµ¹æ»ç¼±Ä¡·á(MRgRT)¿Í °°Àº ±â¼ú Çõ½ÅÀº Ä¡·áÀÇ Á¤È®¼º°ú È¿°ú¸¦ ³ô¿© ½ÃÀå °³Ã´¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë¿Í Àúħ½ÀÀû ¾Ï Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¾Ï ºÐ¾ß ¹æ»ç¼± Ä¡·áÀÇ Àü¹ÝÀûÀÎ ½ÃÀå ¼ºÀå°ú ½ÃÀå ÀáÀç·Â¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.
Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
¹æ»ç¼± À¯Çüº°·Î º¸¸é, ±¤¹üÀ§ÇÑ ¾ÏÁ¾¿¡ Àû¿ëÇÒ ¼ö ÀÖ°í ÀÌ ±â¼úÀ» °®Ãá Ä¡·á ¼¾ÅͰ¡ ³Î¸® º¸±ÞµÇ¾î Àֱ⠶§¹®¿¡ ¿ÜºÎ ¹æ»ç¼± Ä¡·áÀÌ ÇöÀç ¼¼°è¿¡¼ °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ºñħ½ÀÀû Ư¼º°ú È®¸³µÈ ÀÓ»ó ÇÁ·ÎÅäÄÝÀÌ ¹æ»ç¼± Ä¡·á ½ÃÀå¿¡¼ Áö¹èÀûÀÎ À§Ä¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
Ä¡·áº°·Î´Â °µµº¯Á¶¹æ»ç¼±Ä¡·á(IMRT)°¡ ÇöÀç °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÁÖ·Î ºöÀÇ °µµ¸¦ Á¶ÀýÇÏ¸é¼ Á¾¾çÀÇ ¸ð¾ç¿¡ µû¶ó ¹æ»ç¼±·®À» Á¤È®ÇÏ°Ô Á¶ÀýÇÒ ¼ö Àִ ÷´Ü ±â´ÉÀÌ ´Ù¾çÇÑ ¾Ï Ä¡·á¿¡ ³Î¸® äÅÃµÇ¾î ±¹¼Ò Á¦¾î¸¦ °³¼±ÇÏ´Â È¿°ú°¡ ÀÔÁõµÇ¾ú±â ¶§¹®ÀÔ´Ï´Ù.
ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â º´¿ø ¹× ÀÇ·á ¿¬±¸ ±â°üÀÌ ÇöÀç °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÁÖ·Î ¹æ»ç¼± Ä¡·á°¡ ±âº» Ä¡·á ¼ö´ÜÀÎ º´¿øÀÌ Á¾ÇÕÀûÀÎ ¾Ï Ä¡·á ¼ºñ½º¸¦ Á¦°øÇϰí, º´¿øÀÌ ¸¹Àº ȯÀÚ¸¦ Ä¡·áÇϰí, ÀÇ·á ¿¬±¸ ±â°üÀÌ Á¶»ç Ȱµ¿À» ¼öÇàÇϱ⠶§¹®ÀÔ´Ï´Ù.
Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ÇöÀç ¾Ï ¹æ»ç¼± Ä¡·á ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È Á¾¾ç ¹æ»ç¼± Ä¡·á ½ÃÀå¿¡¼ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¾Ï ºÐ¾ß ¹æ»ç¼± Ä¡·á ½ÃÀå¿¡ Àû±ØÀûÀ¸·Î ÁøÃâÇϰí ÀÖ´Â ÁÖ¿ä ±â¾÷ Áß ÀμöµÇÁö ¾ÊÀº ±â¾÷À¸·Î´Â Accuray Incorporated, Elekta AB, Mevion Medical Systems, Siemens Healthineers (which includes Varian Medical Systems), IBA Worldwide, ViewRay Technologies Inc, Perspective Therapeutics Inc (formerly Isoray Inc), Hitachi Ltd (part of Hitachi High-Tech Corporation), Sumitomo Heavy Industries Ltd, Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG) µîÀÌ ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå Á¾¾çÇÐ ¼¼°èÀÇ ¹æ»ç¼± Ä¡·á ½ÃÀå ÀλçÀÌÆ®
- ½ÃÀå ÇöȲ
- Á¾¾çÇÐ ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
- ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
- PESTEL ºÐ¼®
- Á¾¾çÇÐ ½ÃÀå ¹æ»ç¼± Ä¡·á ÀÀ¿ë µ¿Çâ
- ¹ë·ùüÀÎ ºÐ¼®
- COVID-19ÀÇ ¿µÇ⠺м®
Á¦5Àå ¼¼°èÀÇ Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå : ¹æ»ç¼± À¯Çüº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- ¿ÜºÎ ºö Á¶»ç
- ³»ºÎ ºö Á¶»ç
Á¦6Àå ¼¼°èÀÇ Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå : Ä¡·áº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- Á¤À§ ¹æ»ç¼± ¼ö¼ú(SRS)
- ¿µ»ó À¯µµ ¹æ»ç¼± Ä¡·á(IGRT)
- °µµ Á¶Àý ¹æ»ç¼± Ä¡·á(IMRT)
- üÀû º¯Á¶ ¾ÆÅ© Ä¡·á(VMAT)
- ±ÙÁ¢ ¹æ»ç¼± Ä¡·á
Á¦7Àå ¼¼°èÀÇ Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- º´¿ø ¹× ÀÇ·á ¿¬±¸±â°ü
- Àü¹® ¹æ»ç¼± Ä¡·á¼¾ÅÍ
Á¦8Àå ¼¼°èÀÇ Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå : Áö¿ªº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå Æò°¡ : Áö¿ªº°, 2020-2034³â
- ºÏ¹Ì
- ºÏ¹Ì : ¹æ»ç¼± À¯Çüº°, 2020-2034³â
- ºÏ¹Ì : Ä¡·áº°, 2020-2034³â
- ºÏ¹Ì : ÃÖÁ¾»ç¿ëÀÚº°, 2020-2034³â
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- À¯·´ : ¹æ»ç¼± À¯Çüº°, 2020-2034³â
- À¯·´ : Ä¡·áº°, 2020-2034³â
- À¯·´ : ÃÖÁ¾»ç¿ëÀÚº°, 2020-2034³â
- ¿µ±¹
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ³×´ú¶õµå
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ¹æ»ç¼± À¯Çüº°, 2020-2034³â
- ¾Æ½Ã¾ÆÅÂÆò¾ç : Ä¡·áº°, 2020-2034³â
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ÃÖÁ¾»ç¿ëÀÚº°, 2020-2034³â
- Áß±¹
- Àεµ
- ¸»·¹À̽þÆ
- ÀϺ»
- Àεµ³×½Ã¾Æ
- Çѱ¹
- È£ÁÖ
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¹æ»ç¼± À¯Çüº°, 2020-2034³â
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Ä¡·áº°, 2020-2034³â
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾»ç¿ëÀÚº°, 2020-2034³â
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- À̽º¶ó¿¤
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¶óƾ¾Æ¸Þ¸®Ä« : ¹æ»ç¼± À¯Çüº°, 2020-2034³â
- ¶óƾ¾Æ¸Þ¸®Ä« : Ä¡·áº°, 2020-2034³â
- ¶óƾ¾Æ¸Þ¸®Ä« : ÃÖÁ¾»ç¿ëÀÚº°, 2020-2034³â
- ¸ß½ÃÄÚ
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
Á¦9Àå °æÀï ±¸µµ
- È®´ë¿Í Àμö ºÐ¼®
- Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³
Á¦10Àå ±â¾÷ °³¿ä
- Accuray Incorporated
- Carl Zeiss Meditec AG(a subsidiary of Carl Zeiss AG)
- Elekta AB
- Hitachi Ltd(part of Hitachi High-Tech Corporation)
- IBA Worldwide
- Mevion Medical Systems
- Perspective Therapeutics Inc(formerly Isoray Inc)
- Siemens Healthineers(which includes Varian Medical Systems)
- Sumitomo Heavy Industries Ltd
- ViewRay Technologies Inc
LSH
The global Radiation therapy in the oncology market size is expected to reach USD 15.43 billion by 2034, according to a new study by Polaris Market Research. The report "Radiation Therapy in the Oncology Market Size, Share, Trends, Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), Therapy, End-User, and Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Radiation therapy in the oncology market encompasses the utilization of high-energy ionizing radiation to treat and manage cancer. This therapeutic modality involves precisely delivering radiation to malignant tumors, aiming to eradicate cancerous cells or impede their growth while minimizing damage to surrounding healthy tissues and organs. Various radiation sources and delivery techniques are employed, including external beam radiation therapy (EBRT) using linear accelerators, internal radiation therapy (brachytherapy) involving the placement of radioactive sources within the body, and systemic radiation therapy using radioactive substances that circulate throughout the body. The radiation oncology field integrates sophisticated imaging, treatment planning software, and specialized medical expertise to optimize treatment outcomes for cancer patients across diverse tumor types and stages.
The market is a critical segment within the broader radiation oncology landscape, driven by the increasing global incidence of cancer and continuous advancements in radiation delivery technologies. The market overview reveals a dynamic environment influenced by factors such as the growing adoption of personalized medicine, which tailors radiation treatments to individual patient and tumor characteristics. Technological innovations, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), proton therapy, and magnetic resonance-guided radiation therapy (MRgRT), are enhancing treatment precision and efficacy, thereby fueling market development. Furthermore, the expanding healthcare infrastructure in emerging economies and the rising demand for minimally invasive cancer treatment options contribute significantly to the overall market growth and market potential of radiation therapy in oncology.
Radiation Therapy in the Oncology Market Report Highlights:
By radiation type, the external beam radiation segment currently holds the highest market share globally due to its broad applicability across a wide range of cancer types and the widespread availability of treatment centers equipped with this technology. Its non-invasive nature and established clinical protocols contribute to its dominant position in the radiation therapy market.
By therapy, intensity-modulated radiation therapy (IMRT) presently commands the largest market share. This is primarily because of its advanced capability to precisely conform the radiation dose to the tumor's shape while modulating the beam's intensity, leading to widespread adoption across various cancer treatments and its proven efficacy in improving local control.
By end-user, the hospitals & medical research institutes segment currently accounts for the largest market share. This is mainly due to the comprehensive cancer care services offered by hospitals, where radiation therapy is a fundamental treatment modality, along with the significant patient volumes they handle and the research activities undertaken by medical research institutes.
By region, North America currently holds the largest market share in the radiation therapy in the oncology market. The Asia Pacific region is anticipated to exhibit the highest growth rate in the radiation therapy in the oncology market over the forecast period.
The major players actively involved in the radiation therapy in the oncology market, who have not been acquired, include Accuray Incorporated, Elekta AB, Mevion Medical Systems, Siemens Healthineers (which includes Varian Medical Systems), IBA Worldwide, ViewRay Technologies Inc, Perspective Therapeutics Inc (formerly Isoray Inc), Hitachi Ltd (part of Hitachi High-Tech Corporation), Sumitomo Heavy Industries Ltd, and Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG).
Polaris Market Research has segmented the Radiation Therapy in the Oncology market report based on radiation type, therapy, end-user, and region:
By Radiation Type Outlook (Revenue - USD Billion, 2020-2034)
External Beam Radiation
Internal Beam Radiation
By Therapy Outlook (Revenue - USD Billion, 2020-2034)
Stereotactic Radiosurgery (SRS)
Image-Guided Radiation Therapy (IGRT)
Intensity-Modulated Radiation Therapy (IMRT)
Volumetric-Modulated Arc Therapy (VMAT)
Brachytherapy
By End-User Outlook (Revenue - USD Billion, 2020-2034)
Hospitals & Medical Research Institutes
Specialized Radiotherapy Centers
By Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
4. Global Radiation Therapy in the Oncology Market Insights
- 4.1. Radiation Therapy in the Oncology Market - Market Snapshot
- 4.2. Radiation Therapy in the Oncology Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Global Cancer Incidence Driving Market Demand
- 4.2.1.2. Technological Advancements Enhancing Treatment Efficacy
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of radiation equipment
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Radiation Therapy in the Oncology Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Radiation Therapy in the Oncology Market, by Radiation Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 5.3. External Beam Radiation
- 5.3.1. Global Radiation Therapy in the Oncology Market, by External Beam Radiation, by Region, 2020-2034 (USD Billion)
- 5.4. Internal Beam Radiation
- 5.4.1. Global Radiation Therapy in the Oncology Market, by Internal Beam Radiation, by Region, 2020-2034 (USD Billion)
6. Global Radiation Therapy in the Oncology Market, by Therapy
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 6.3. Stereotactic Radiosurgery (SRS)
- 6.3.1. Global Radiation Therapy in the Oncology Market, by Stereotactic Radiosurgery (SRS), by Region, 2020-2034 (USD Billion)
- 6.4. Image-Guided Radiation Therapy (IGRT)
- 6.4.1. Global Radiation Therapy in the Oncology Market, by Image-Guided Radiation Therapy (IGRT), by Region, 2020-2034 (USD Billion)
- 6.5. Intensity-Modulated Radiation Therapy (IMRT)
- 6.5.1. Global Radiation Therapy in the Oncology Market, by Intensity-Modulated Radiation Therapy (IMRT), by Region, 2020-2034 (USD Billion)
- 6.6. Volumetric-Modulated Arc Therapy (VMAT)
- 6.6.1. Global Radiation Therapy in the Oncology Market, by Volumetric-Modulated Arc Therapy (VMAT), by Region, 2020-2034 (USD Billion)
- 6.7. Brachytherapy
- 6.7.1. Global Radiation Therapy in the Oncology Market, by Brachytherapy, by Region, 2020-2034 (USD Billion)
7. Global Radiation Therapy in the Oncology Market, by End-User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 7.3. Hospitals & Medical Research Institutes
- 7.3.1. Global Radiation Therapy in the Oncology Market, by Hospitals & Medical Research Institutes, by Region, 2020-2034 (USD Billion)
- 7.4. Specialized Radiotherapy Centers
- 7.4.1. Global Radiation Therapy in the Oncology Market, by Specialized Radiotherapy Centers, by Region, 2020-2034 (USD Billion)
8. Global Radiation Therapy in the Oncology Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Radiation Therapy in the Oncology Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Radiation Therapy in the Oncology Market - North America
- 8.3.1. North America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.3.3. North America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.3.4. Radiation Therapy in the Oncology Market - U.S.
- 8.3.4.1. U.S.: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.3.5. Radiation Therapy in the Oncology Market - Canada
- 8.3.5.1. Canada: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4. Radiation Therapy in the Oncology Market - Europe
- 8.4.1. Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.3. Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.4. Radiation Therapy in the Oncology Market - UK
- 8.4.4.1. UK: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.5. Radiation Therapy in the Oncology Market - France
- 8.4.5.1. France: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.4.5.2. France: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.5.3. France: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.6. Radiation Therapy in the Oncology Market - Germany
- 8.4.6.1. Germany: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.7. Radiation Therapy in the Oncology Market - Italy
- 8.4.7.1. Italy: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.8. Radiation Therapy in the Oncology Market - Spain
- 8.4.8.1. Spain: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.9. Radiation Therapy in the Oncology Market - Netherlands
- 8.4.9.1. Netherlands: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.10. Radiation Therapy in the Oncology Market - Russia
- 8.4.10.1. Russia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.11. Radiation Therapy in the Oncology Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5. Radiation Therapy in the Oncology Market - Asia Pacific
- 8.5.1. Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.4. Radiation Therapy in the Oncology Market - China
- 8.5.4.1. China: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.5.4.2. China: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.4.3. China: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.5. Radiation Therapy in the Oncology Market - India
- 8.5.5.1. India: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.5.5.2. India: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.5.3. India: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.6. Radiation Therapy in the Oncology Market - Malaysia
- 8.5.6.1. Malaysia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.7. Radiation Therapy in the Oncology Market - Japan
- 8.5.7.1. Japan: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.8. Radiation Therapy in the Oncology Market - Indonesia
- 8.5.8.1. Indonesia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.9. Radiation Therapy in the Oncology Market - South Korea
- 8.5.9.1. South Korea: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.10. Radiation Therapy in the Oncology Market - Australia
- 8.5.10.1. Australia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.11. Radiation Therapy in the Oncology Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6. Radiation Therapy in the Oncology Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.4. Radiation Therapy in the Oncology Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.5. Radiation Therapy in the Oncology Market - UAE
- 8.6.5.1. UAE: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.6. Radiation Therapy in the Oncology Market - Israel
- 8.6.6.1. Israel: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.7. Radiation Therapy in the Oncology Market - South Africa
- 8.6.7.1. South Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.8. Radiation Therapy in the Oncology Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7. Radiation Therapy in the Oncology Market - Latin America
- 8.7.1. Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7.4. Radiation Therapy in the Oncology Market - Mexico
- 8.7.4.1. Mexico: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7.5. Radiation Therapy in the Oncology Market - Brazil
- 8.7.5.1. Brazil: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7.6. Radiation Therapy in the Oncology Market - Argentina
- 8.7.6.1. Argentina: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7.7. Radiation Therapy in the Oncology Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Accuray Incorporated
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Elekta AB
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Hitachi Ltd (part of Hitachi High-Tech Corporation)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. IBA Worldwide
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Mevion Medical Systems
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Perspective Therapeutics Inc (formerly Isoray Inc)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Siemens Healthineers (which includes Varian Medical Systems)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Sumitomo Heavy Industries Ltd
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. ViewRay Technologies Inc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development